Effects of COVID-19 on bone health in different age groups
Impacts of SARS-CoV-2 Infection and Age on Musculoskeletal Health
This study is looking at how COVID-19 affects bone health, especially in older adults, to find out if the virus causes bone loss and to help create ways to protect bones after infection.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10891659 on NIH RePORTER |
What this research studies
This research investigates how SARS-CoV-2 infection impacts musculoskeletal health, particularly focusing on bone metabolism and homeostasis. It aims to understand the long-term effects of COVID-19 on bone mass, especially in older adults who may be more vulnerable to severe infections. By studying animal models, the researchers will assess changes in bone density and the activity of bone-resorbing cells following infection. The ultimate goal is to develop treatment strategies to mitigate bone loss associated with COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have had a confirmed SARS-CoV-2 infection, particularly older adults who may be at higher risk for bone health issues.
Not a fit: Patients who have not been infected with SARS-CoV-2 or those with pre-existing severe bone health conditions unrelated to COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help prevent or reduce bone loss in patients who have recovered from COVID-19.
How similar studies have performed: Preliminary studies in animal models have shown significant changes in bone health following SARS-CoV-2 infection, indicating that this area of research is both relevant and potentially impactful.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Awosanya, Olatundun Dupe — Indiana University Indianapolis
- Study coordinator: Awosanya, Olatundun Dupe
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.